Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers

Area of Science:

• Neuroscience
• Biochemistry
• Pathology

Background:

• Protein aggregate deposition is a key feature in neurodegenerative diseases (NDs) such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS).
• These diseases can involve mixed proteinopathies, where multiple misfolded proteins coexist.
• Current lack of cures necessitates a deeper understanding of protein aggregation mechanisms for developing diagnostics and therapeutics.

Purpose of the Study:

• To develop a sensitive and specific method for distinguishing and quantifying multimeric/oligomeric forms of aggregated proteins from their monomeric counterparts.
• To provide a tool that can aid in the exploration of diagnostic and treatment strategies for neurodegenerative diseases.

Main Methods:

• A Multimer Detection System (MDS) was designed to target aggregated proteins.
• MDS utilizes antibodies that bind to accessible epitopes on aggregated proteins, differentiating them from monomers where epitopes are occupied.

Main Results:

• The MDS can effectively distinguish and quantify multimeric/oligomeric protein forms from monomeric forms.
• The system generates signals specifically from oligomers, not monomers, due to the binding mechanism.

Conclusions:

• The Multimer Detection System (MDS) offers a sensitive and specific solution for measuring various conformations of aggregated proteins.
• This technology has the potential to advance diagnostic and therapeutic strategies for neurodegenerative diseases by enabling better measurement of pathological protein species.